The Sidney Kimmel Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website: http://www.hopkinsmedicine.org/kimmel_cancer_center

Clinical Trials

Scrambler Therapy in the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy

Not Applicable

Completed

Conditions: Neuropathy

Interventions: Device: Scrambler Therapy
Device: Sham Therapy

First Posted Date: 2014-04-11

Last Posted Date: 2018-08-17

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 37

Registration Number: NCT02111174

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

A Pre-surgical Study of LDE225 in Men With High-risk Localized Prostate Cancer

Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Drug: LDE225

First Posted Date: 2014-04-11

Last Posted Date: 2019-03-07

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 14

Registration Number: NCT02111187

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin

Phase 2

Terminated

Conditions: Breast Cancer
Stage II Breast Cancer
Stage III Breast Cancer
Stage I Breast Cancer

Interventions: Drug: Simvastatin
Drug: Doxorubicin/cyclophosphamide

First Posted Date: 2014-03-26

Last Posted Date: 2024-07-09

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 34

Registration Number: NCT02096588

Locations: 🇺🇸
Kimmel Cancer Center at Johns Hopkins at Sibley Memorial Hospital, Washington, District of Columbia, United States
🇺🇸
Kimmel Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Testosterone cypionate
Drug: Testosterone Enanthate
Drug: Enzalutamide
Drug: Abiraterone acetate

First Posted Date: 2014-03-18

Last Posted Date: 2022-06-27

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 112

Registration Number: NCT02090114

Locations: 🇺🇸
Sibley Memorial Hospital, Washington, District of Columbia, United States
🇺🇸
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Red Cell Transfusion Goals in Patients With Acute Leukemias

Phase 1

Completed

Conditions: Acute Promyelocytic Leukemia (APL)
Acute Myelogenous Leukemia (AML)
Acute Lymphocytic Leukemia (ALL)
Acute Lymphoblastic Leukemia

Interventions: Biological: Red blood cell transfusion

First Posted Date: 2014-03-13

Last Posted Date: 2019-01-24

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 90

Registration Number: NCT02086773

Locations: 🇺🇸
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)

Phase 1

Terminated

Conditions: Lupus Erythematosus
Graft-versus-host Disease

Interventions: Drug: Cyclophosphamide
Drug: Fludarabine
Drug: Tacrolimus
Drug: Mycophenolate Mofetil
Drug: Rabbit antithymocyte globulin
Radiation: Total body irradiation
Biological: Allogeneic bone marrow transplant

First Posted Date: 2014-03-06

Last Posted Date: 2019-10-02

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 1

Registration Number: NCT02080195

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors

Early Phase 1

Terminated

Conditions: Non-Hodgkin Lymphoma
Hodgkin Lymphoma
EBV
Kaposi Sarcoma
Gastric Cancer
Castleman Disease
Nasopharyngeal Cancer

Interventions: Drug: Nelfinavir

First Posted Date: 2014-03-06

Last Posted Date: 2016-06-10

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 1

Registration Number: NCT02080416

Locations: 🇺🇸
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Robot-Assisted MRI-Guided Prostate Biopsy

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Device: Robot-assisted prostate biopsy

First Posted Date: 2014-03-06

Last Posted Date: 2019-01-14

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 5

Registration Number: NCT02080052

Locations: 🇺🇸
The Johns Hopkins Hospital, Baltimore, Maryland, United States

A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer

Phase 1

Completed

Conditions: Metastatic Pancreatic Adenocarcinoma

Interventions: Drug: metformin alone (Arm A)
Drug: metformin (Arm B)
Drug: rapamycin (Arm B)

First Posted Date: 2014-01-29

Last Posted Date: 2021-04-12

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 22

Registration Number: NCT02048384

Locations: 🇺🇸
Scottsdale Healthcare Hospitals DBA Honor Health, Scottsdale, Arizona, United States
🇺🇸
Johns Hopkins SKCCC, Baltimore, Maryland, United States

A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL

Early Phase 1

Completed

Conditions: Acute Lymphoblastic Leukemia (ALL)

Interventions: Drug: Allopurinol

First Posted Date: 2014-01-28

Last Posted Date: 2022-06-21

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 34

Registration Number: NCT02046694

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸
Texas Children's Cancer and Hematology Centers, Houston, Texas, United States
🇺🇸
Seattle Children's Hospital, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy